nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A7—Rifampicin—leprosy	0.0809	0.117	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0809	0.117	CbGbCtD
Quetiapine—CYP3A7—Dapsone—leprosy	0.0668	0.0966	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0668	0.0966	CbGbCtD
Quetiapine—CYP3A5—Thalidomide—leprosy	0.0626	0.0906	CbGbCtD
Quetiapine—CYP3A5—Rifampicin—leprosy	0.0607	0.0878	CbGbCtD
Quetiapine—CYP2C19—Thalidomide—leprosy	0.0505	0.0731	CbGbCtD
Quetiapine—CYP3A5—Dapsone—leprosy	0.0501	0.0725	CbGbCtD
Quetiapine—CYP2C19—Rifampicin—leprosy	0.0489	0.0708	CbGbCtD
Quetiapine—CYP2C19—Dapsone—leprosy	0.0404	0.0584	CbGbCtD
Quetiapine—ABCB1—Rifampicin—leprosy	0.0395	0.0571	CbGbCtD
Quetiapine—CYP3A4—Rifampicin—leprosy	0.0237	0.0342	CbGbCtD
Quetiapine—CYP3A4—Dapsone—leprosy	0.0195	0.0283	CbGbCtD
Quetiapine—DRD5—eyelid—leprosy	0.0137	0.124	CbGeAlD
Quetiapine—Hormone level abnormal—Thalidomide—leprosy	0.0103	0.052	CcSEcCtD
Quetiapine—Orchitis—Thalidomide—leprosy	0.00843	0.0425	CcSEcCtD
Quetiapine—Orchitis noninfective—Thalidomide—leprosy	0.00775	0.0391	CcSEcCtD
Quetiapine—HTR1B—trigeminal nerve—leprosy	0.00618	0.0558	CbGeAlD
Quetiapine—HTR1D—trigeminal nerve—leprosy	0.00599	0.0541	CbGeAlD
Quetiapine—HTR3A—cranial nerve—leprosy	0.00525	0.0474	CbGeAlD
Quetiapine—HRH1—nose—leprosy	0.00454	0.041	CbGeAlD
Quetiapine—HTR1B—cranial nerve—leprosy	0.00441	0.0398	CbGeAlD
Quetiapine—HTR1D—cranial nerve—leprosy	0.00427	0.0385	CbGeAlD
Quetiapine—CHRM5—skin epidermis—leprosy	0.00384	0.0347	CbGeAlD
Quetiapine—Enuresis—Thalidomide—leprosy	0.0034	0.0172	CcSEcCtD
Quetiapine—HTR7—cranial nerve—leprosy	0.0034	0.0307	CbGeAlD
Quetiapine—Suicide attempt—Dapsone—leprosy	0.00334	0.0169	CcSEcCtD
Quetiapine—HTR2A—trigeminal nerve—leprosy	0.00297	0.0269	CbGeAlD
Quetiapine—DRD1—nerve—leprosy	0.00279	0.0252	CbGeAlD
Quetiapine—HTR3A—nerve—leprosy	0.00269	0.0243	CbGeAlD
Quetiapine—Hypochromic anaemia—Thalidomide—leprosy	0.00251	0.0126	CcSEcCtD
Quetiapine—HTR7—peripheral nervous system—leprosy	0.00223	0.0202	CbGeAlD
Quetiapine—Parkinsonism—Thalidomide—leprosy	0.00214	0.0108	CcSEcCtD
Quetiapine—HTR2A—cranial nerve—leprosy	0.00212	0.0191	CbGeAlD
Quetiapine—Neck stiffness—Thalidomide—leprosy	0.00204	0.0103	CcSEcCtD
Quetiapine—Cerebral ischaemia—Thalidomide—leprosy	0.00201	0.0101	CcSEcCtD
Quetiapine—Embolism venous—Thalidomide—leprosy	0.00192	0.00972	CcSEcCtD
Quetiapine—Nuchal rigidity—Thalidomide—leprosy	0.00187	0.00945	CcSEcCtD
Quetiapine—HTR2A—hindlimb—leprosy	0.00179	0.0161	CbGeAlD
Quetiapine—HTR1B—blood vessel—leprosy	0.00177	0.016	CbGeAlD
Quetiapine—Hostility—Thalidomide—leprosy	0.00175	0.00886	CcSEcCtD
Quetiapine—HTR7—nerve—leprosy	0.00174	0.0157	CbGeAlD
Quetiapine—Sexual dysfunction—Thalidomide—leprosy	0.00173	0.00875	CcSEcCtD
Quetiapine—HTR1D—blood vessel—leprosy	0.00172	0.0155	CbGeAlD
Quetiapine—Suicide attempt—Thalidomide—leprosy	0.00171	0.00864	CcSEcCtD
Quetiapine—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00167	0.00844	CcSEcCtD
Quetiapine—DRD2—nerve—leprosy	0.00165	0.0149	CbGeAlD
Quetiapine—ADRA2A—peripheral nervous system—leprosy	0.00164	0.0148	CbGeAlD
Quetiapine—Platelet count decreased—Thalidomide—leprosy	0.00163	0.00824	CcSEcCtD
Quetiapine—Enlargement abdomen—Thalidomide—leprosy	0.00161	0.00815	CcSEcCtD
Quetiapine—Toothache—Thalidomide—leprosy	0.0016	0.00806	CcSEcCtD
Quetiapine—Deep vein thrombosis—Thalidomide—leprosy	0.0016	0.00806	CcSEcCtD
Quetiapine—Myasthenia—Thalidomide—leprosy	0.00155	0.0078	CcSEcCtD
Quetiapine—Psoriasis—Thalidomide—leprosy	0.00155	0.0078	CcSEcCtD
Quetiapine—HTR2A—appendage—leprosy	0.00153	0.0138	CbGeAlD
Quetiapine—Hypothyroidism—Thalidomide—leprosy	0.00151	0.00764	CcSEcCtD
Quetiapine—Galactorrhoea—Thalidomide—leprosy	0.0015	0.00756	CcSEcCtD
Quetiapine—Menstrual disorder—Thalidomide—leprosy	0.00143	0.00719	CcSEcCtD
Quetiapine—Intestinal obstruction—Thalidomide—leprosy	0.00143	0.00719	CcSEcCtD
Quetiapine—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00143	0.00719	CcSEcCtD
Quetiapine—Neuralgia—Thalidomide—leprosy	0.0014	0.00706	CcSEcCtD
Quetiapine—HTR2A—peripheral nervous system—leprosy	0.00139	0.0126	CbGeAlD
Quetiapine—Cyanosis—Thalidomide—leprosy	0.00137	0.00693	CcSEcCtD
Quetiapine—HTR7—blood vessel—leprosy	0.00137	0.0124	CbGeAlD
Quetiapine—CHRM5—eye—leprosy	0.00137	0.0124	CbGeAlD
Quetiapine—Metrorrhagia—Thalidomide—leprosy	0.00136	0.00686	CcSEcCtD
Quetiapine—Hyperlipidaemia—Thalidomide—leprosy	0.00135	0.0068	CcSEcCtD
Quetiapine—Psychotic disorder—Dapsone—leprosy	0.00135	0.00679	CcSEcCtD
Quetiapine—Stupor—Thalidomide—leprosy	0.0013	0.00657	CcSEcCtD
Quetiapine—DRD4—testis—leprosy	0.00127	0.0115	CbGeAlD
Quetiapine—Amblyopia—Thalidomide—leprosy	0.00126	0.00635	CcSEcCtD
Quetiapine—Skin ulcer—Thalidomide—leprosy	0.00125	0.0063	CcSEcCtD
Quetiapine—Nasopharyngitis—Dapsone—leprosy	0.00123	0.00622	CcSEcCtD
Quetiapine—Muscular weakness—Dapsone—leprosy	0.00121	0.00613	CcSEcCtD
Quetiapine—Influenza—Dapsone—leprosy	0.00119	0.00601	CcSEcCtD
Quetiapine—CHRM5—skin of body—leprosy	0.00119	0.0107	CbGeAlD
Quetiapine—Endocrine disorder—Thalidomide—leprosy	0.00117	0.00591	CcSEcCtD
Quetiapine—Pancreatitis—Dapsone—leprosy	0.00117	0.00589	CcSEcCtD
Quetiapine—Blood disorder—Thalidomide—leprosy	0.00116	0.00587	CcSEcCtD
Quetiapine—Acne—Thalidomide—leprosy	0.00115	0.00583	CcSEcCtD
Quetiapine—Amenorrhoea—Thalidomide—leprosy	0.00111	0.00558	CcSEcCtD
Quetiapine—Accidental injury—Thalidomide—leprosy	0.0011	0.00554	CcSEcCtD
Quetiapine—Photosensitivity reaction—Dapsone—leprosy	0.00109	0.00549	CcSEcCtD
Quetiapine—HTR2A—nerve—leprosy	0.00109	0.00981	CbGeAlD
Quetiapine—Musculoskeletal stiffness—Thalidomide—leprosy	0.00108	0.00547	CcSEcCtD
Quetiapine—Skin discolouration—Thalidomide—leprosy	0.00108	0.00543	CcSEcCtD
Quetiapine—HTR1E—nervous system—leprosy	0.00107	0.0097	CbGeAlD
Quetiapine—Arthropathy—Thalidomide—leprosy	0.00107	0.00539	CcSEcCtD
Quetiapine—Thinking abnormal—Thalidomide—leprosy	0.00106	0.00536	CcSEcCtD
Quetiapine—Drug interaction—Thalidomide—leprosy	0.00105	0.00529	CcSEcCtD
Quetiapine—Dyskinesia—Thalidomide—leprosy	0.00103	0.00522	CcSEcCtD
Quetiapine—Leukocytosis—Thalidomide—leprosy	0.00103	0.00522	CcSEcCtD
Quetiapine—H1F0—skin of body—leprosy	0.00103	0.00927	CbGeAlD
Quetiapine—Creatinine increased—Thalidomide—leprosy	0.00102	0.00515	CcSEcCtD
Quetiapine—Bone pain—Thalidomide—leprosy	0.00101	0.00512	CcSEcCtD
Quetiapine—Sinusitis—Dapsone—leprosy	0.000996	0.00503	CcSEcCtD
Quetiapine—Gait disturbance—Thalidomide—leprosy	0.000995	0.00502	CcSEcCtD
Quetiapine—Coordination abnormal—Thalidomide—leprosy	0.000989	0.00499	CcSEcCtD
Quetiapine—Neck pain—Thalidomide—leprosy	0.000983	0.00496	CcSEcCtD
Quetiapine—Phosphatase alkaline increased—Thalidomide—leprosy	0.000971	0.0049	CcSEcCtD
Quetiapine—Pulmonary embolism—Thalidomide—leprosy	0.000971	0.0049	CcSEcCtD
Quetiapine—CHRM4—testis—leprosy	0.000959	0.00866	CbGeAlD
Quetiapine—Pharyngitis—Dapsone—leprosy	0.000946	0.00477	CcSEcCtD
Quetiapine—CHRM4—nervous system—leprosy	0.000941	0.0085	CbGeAlD
Quetiapine—Depressed level of consciousness—Thalidomide—leprosy	0.000938	0.00473	CcSEcCtD
Quetiapine—Candida infection—Thalidomide—leprosy	0.000927	0.00468	CcSEcCtD
Quetiapine—HTR1D—eye—leprosy	0.000914	0.00825	CbGeAlD
Quetiapine—Dry eye—Thalidomide—leprosy	0.000897	0.00453	CcSEcCtD
Quetiapine—Cramps of lower extremities—Thalidomide—leprosy	0.000892	0.0045	CcSEcCtD
Quetiapine—Tinnitus—Dapsone—leprosy	0.000888	0.00448	CcSEcCtD
Quetiapine—Rash maculo-papular—Thalidomide—leprosy	0.000883	0.00446	CcSEcCtD
Quetiapine—DRD3—nervous system—leprosy	0.000875	0.00791	CbGeAlD
Quetiapine—Gynaecomastia—Thalidomide—leprosy	0.000869	0.00439	CcSEcCtD
Quetiapine—HTR2A—blood vessel—leprosy	0.000853	0.0077	CbGeAlD
Quetiapine—Hypertonia—Thalidomide—leprosy	0.000851	0.0043	CcSEcCtD
Quetiapine—Hyperkinesia—Thalidomide—leprosy	0.000847	0.00428	CcSEcCtD
Quetiapine—Mental disability—Thalidomide—leprosy	0.000843	0.00425	CcSEcCtD
Quetiapine—HTR6—nervous system—leprosy	0.000843	0.00761	CbGeAlD
Quetiapine—Euphoric mood—Thalidomide—leprosy	0.000835	0.00421	CcSEcCtD
Quetiapine—Lymphadenopathy—Thalidomide—leprosy	0.000826	0.00417	CcSEcCtD
Quetiapine—DRD5—nervous system—leprosy	0.00082	0.00741	CbGeAlD
Quetiapine—Thrombophlebitis—Thalidomide—leprosy	0.000815	0.00411	CcSEcCtD
Quetiapine—Diabetes mellitus—Thalidomide—leprosy	0.000811	0.00409	CcSEcCtD
Quetiapine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000811	0.00409	CcSEcCtD
Quetiapine—Gastroenteritis—Thalidomide—leprosy	0.000796	0.00402	CcSEcCtD
Quetiapine—Deafness—Thalidomide—leprosy	0.000788	0.00398	CcSEcCtD
Quetiapine—Eczema—Thalidomide—leprosy	0.000785	0.00396	CcSEcCtD
Quetiapine—Vision blurred—Dapsone—leprosy	0.000782	0.00395	CcSEcCtD
Quetiapine—Eye pain—Thalidomide—leprosy	0.000781	0.00394	CcSEcCtD
Quetiapine—H1F0—tendon—leprosy	0.000781	0.00705	CbGeAlD
Quetiapine—Cardiac failure congestive—Thalidomide—leprosy	0.000777	0.00392	CcSEcCtD
Quetiapine—Injury—Thalidomide—leprosy	0.000767	0.00387	CcSEcCtD
Quetiapine—Renal failure acute—Thalidomide—leprosy	0.000764	0.00386	CcSEcCtD
Quetiapine—Libido decreased—Thalidomide—leprosy	0.00076	0.00384	CcSEcCtD
Quetiapine—Amnesia—Thalidomide—leprosy	0.00075	0.00379	CcSEcCtD
Quetiapine—Increased appetite—Thalidomide—leprosy	0.00075	0.00379	CcSEcCtD
Quetiapine—Dermatitis exfoliative—Thalidomide—leprosy	0.000747	0.00377	CcSEcCtD
Quetiapine—Vertigo—Dapsone—leprosy	0.000745	0.00376	CcSEcCtD
Quetiapine—Atrial fibrillation—Thalidomide—leprosy	0.000744	0.00376	CcSEcCtD
Quetiapine—CHRM5—nervous system—leprosy	0.000736	0.00665	CbGeAlD
Quetiapine—Arthritis—Thalidomide—leprosy	0.000725	0.00366	CcSEcCtD
Quetiapine—Cough—Dapsone—leprosy	0.000724	0.00365	CcSEcCtD
Quetiapine—Hypoglycaemia—Thalidomide—leprosy	0.000722	0.00365	CcSEcCtD
Quetiapine—Cerebrovascular accident—Thalidomide—leprosy	0.00072	0.00363	CcSEcCtD
Quetiapine—Lethargy—Thalidomide—leprosy	0.00072	0.00363	CcSEcCtD
Quetiapine—Hyponatraemia—Thalidomide—leprosy	0.000708	0.00357	CcSEcCtD
Quetiapine—Osteoarthritis—Thalidomide—leprosy	0.000705	0.00356	CcSEcCtD
Quetiapine—Pain in extremity—Thalidomide—leprosy	0.000705	0.00356	CcSEcCtD
Quetiapine—Disturbance in sexual arousal—Thalidomide—leprosy	0.0007	0.00353	CcSEcCtD
Quetiapine—Affect lability—Thalidomide—leprosy	0.000694	0.0035	CcSEcCtD
Quetiapine—Migraine—Thalidomide—leprosy	0.000694	0.0035	CcSEcCtD
Quetiapine—Psychotic disorder—Thalidomide—leprosy	0.000689	0.00348	CcSEcCtD
Quetiapine—DRD2—eye—leprosy	0.000688	0.00621	CbGeAlD
Quetiapine—Face oedema—Thalidomide—leprosy	0.000681	0.00344	CcSEcCtD
Quetiapine—ADRA1B—nervous system—leprosy	0.000672	0.00607	CbGeAlD
Quetiapine—Cardiac arrest—Thalidomide—leprosy	0.00067	0.00338	CcSEcCtD
Quetiapine—Mood swings—Thalidomide—leprosy	0.000668	0.00337	CcSEcCtD
Quetiapine—Ataxia—Thalidomide—leprosy	0.000663	0.00335	CcSEcCtD
Quetiapine—Tachycardia—Dapsone—leprosy	0.000661	0.00334	CcSEcCtD
Quetiapine—Blood creatinine increased—Thalidomide—leprosy	0.000661	0.00333	CcSEcCtD
Quetiapine—ADRA1D—nervous system—leprosy	0.000658	0.00594	CbGeAlD
Quetiapine—Dehydration—Thalidomide—leprosy	0.000656	0.00331	CcSEcCtD
Quetiapine—H1F0—testis—leprosy	0.000647	0.00584	CbGeAlD
Quetiapine—Dry skin—Thalidomide—leprosy	0.000646	0.00326	CcSEcCtD
Quetiapine—Orthostatic hypotension—Thalidomide—leprosy	0.000644	0.00325	CcSEcCtD
Quetiapine—Hypokalaemia—Thalidomide—leprosy	0.000642	0.00324	CcSEcCtD
Quetiapine—Breast disorder—Thalidomide—leprosy	0.000637	0.00322	CcSEcCtD
Quetiapine—Cramp muscle—Thalidomide—leprosy	0.000635	0.00321	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000635	0.00321	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000635	0.00321	CcSEcCtD
Quetiapine—H1F0—nervous system—leprosy	0.000635	0.00573	CbGeAlD
Quetiapine—DRD1—nervous system—leprosy	0.000627	0.00566	CbGeAlD
Quetiapine—Muscular weakness—Thalidomide—leprosy	0.000622	0.00314	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Thalidomide—leprosy	0.000622	0.00314	CcSEcCtD
Quetiapine—Abdominal distension—Thalidomide—leprosy	0.000614	0.0031	CcSEcCtD
Quetiapine—Insomnia—Dapsone—leprosy	0.000612	0.00309	CcSEcCtD
Quetiapine—Influenza—Thalidomide—leprosy	0.000609	0.00308	CcSEcCtD
Quetiapine—Dysphagia—Thalidomide—leprosy	0.000609	0.00308	CcSEcCtD
Quetiapine—HTR3A—nervous system—leprosy	0.000605	0.00547	CbGeAlD
Quetiapine—Eosinophilia—Thalidomide—leprosy	0.000603	0.00305	CcSEcCtD
Quetiapine—Pancreatitis—Thalidomide—leprosy	0.000597	0.00302	CcSEcCtD
Quetiapine—Angina pectoris—Thalidomide—leprosy	0.000594	0.003	CcSEcCtD
Quetiapine—Bronchitis—Thalidomide—leprosy	0.000586	0.00296	CcSEcCtD
Quetiapine—Neutropenia—Thalidomide—leprosy	0.00057	0.00288	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Thalidomide—leprosy	0.000566	0.00286	CcSEcCtD
Quetiapine—Pollakiuria—Thalidomide—leprosy	0.000563	0.00284	CcSEcCtD
Quetiapine—Erectile dysfunction—Thalidomide—leprosy	0.000561	0.00283	CcSEcCtD
Quetiapine—ABCB1—blood vessel—leprosy	0.000559	0.00505	CbGeAlD
Quetiapine—Photosensitivity reaction—Thalidomide—leprosy	0.000556	0.00281	CcSEcCtD
Quetiapine—Weight increased—Thalidomide—leprosy	0.000555	0.0028	CcSEcCtD
Quetiapine—Gastrointestinal pain—Dapsone—leprosy	0.000554	0.00279	CcSEcCtD
Quetiapine—Weight decreased—Thalidomide—leprosy	0.000551	0.00278	CcSEcCtD
Quetiapine—Hyperglycaemia—Thalidomide—leprosy	0.00055	0.00277	CcSEcCtD
Quetiapine—Pneumonia—Thalidomide—leprosy	0.000547	0.00276	CcSEcCtD
Quetiapine—Infestation NOS—Thalidomide—leprosy	0.000543	0.00274	CcSEcCtD
Quetiapine—Infestation—Thalidomide—leprosy	0.000543	0.00274	CcSEcCtD
Quetiapine—HRH1—eye—leprosy	0.000543	0.00491	CbGeAlD
Quetiapine—Depression—Thalidomide—leprosy	0.000542	0.00273	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000539	0.00272	CcSEcCtD
Quetiapine—Body temperature increased—Dapsone—leprosy	0.000535	0.0027	CcSEcCtD
Quetiapine—Abdominal pain—Dapsone—leprosy	0.000535	0.0027	CcSEcCtD
Quetiapine—Stomatitis—Thalidomide—leprosy	0.00053	0.00267	CcSEcCtD
Quetiapine—Conjunctivitis—Thalidomide—leprosy	0.000528	0.00267	CcSEcCtD
Quetiapine—Sweating—Thalidomide—leprosy	0.000521	0.00263	CcSEcCtD
Quetiapine—Epistaxis—Thalidomide—leprosy	0.000513	0.00259	CcSEcCtD
Quetiapine—Sinusitis—Thalidomide—leprosy	0.00051	0.00257	CcSEcCtD
Quetiapine—HTR1B—nervous system—leprosy	0.000508	0.00459	CbGeAlD
Quetiapine—Agranulocytosis—Thalidomide—leprosy	0.000507	0.00256	CcSEcCtD
Quetiapine—CHRM2—nervous system—leprosy	0.000505	0.00456	CbGeAlD
Quetiapine—Bradycardia—Thalidomide—leprosy	0.000497	0.00251	CcSEcCtD
Quetiapine—HTR1D—nervous system—leprosy	0.000492	0.00444	CbGeAlD
Quetiapine—Rhinitis—Thalidomide—leprosy	0.000489	0.00247	CcSEcCtD
Quetiapine—Hepatitis—Thalidomide—leprosy	0.000488	0.00246	CcSEcCtD
Quetiapine—HTR2C—nervous system—leprosy	0.000487	0.0044	CbGeAlD
Quetiapine—Hypoaesthesia—Thalidomide—leprosy	0.000485	0.00245	CcSEcCtD
Quetiapine—Pharyngitis—Thalidomide—leprosy	0.000484	0.00244	CcSEcCtD
Quetiapine—HTR7—tendon—leprosy	0.000482	0.00435	CbGeAlD
Quetiapine—Urinary tract disorder—Thalidomide—leprosy	0.000482	0.00243	CcSEcCtD
Quetiapine—Oedema peripheral—Thalidomide—leprosy	0.000481	0.00243	CcSEcCtD
Quetiapine—Urethral disorder—Thalidomide—leprosy	0.000478	0.00241	CcSEcCtD
Quetiapine—Visual impairment—Thalidomide—leprosy	0.00047	0.00237	CcSEcCtD
Quetiapine—Erythema multiforme—Thalidomide—leprosy	0.000461	0.00233	CcSEcCtD
Quetiapine—CHRM1—nervous system—leprosy	0.00046	0.00415	CbGeAlD
Quetiapine—Eye disorder—Thalidomide—leprosy	0.000456	0.0023	CcSEcCtD
Quetiapine—Tinnitus—Thalidomide—leprosy	0.000455	0.0023	CcSEcCtD
Quetiapine—HTR2A—eye—leprosy	0.000454	0.0041	CbGeAlD
Quetiapine—Cardiac disorder—Thalidomide—leprosy	0.000453	0.00229	CcSEcCtD
Quetiapine—ADRA2C—tendon—leprosy	0.000443	0.004	CbGeAlD
Quetiapine—Angiopathy—Thalidomide—leprosy	0.000443	0.00223	CcSEcCtD
Quetiapine—Immune system disorder—Thalidomide—leprosy	0.000441	0.00222	CcSEcCtD
Quetiapine—Mediastinal disorder—Thalidomide—leprosy	0.00044	0.00222	CcSEcCtD
Quetiapine—Chills—Thalidomide—leprosy	0.000438	0.00221	CcSEcCtD
Quetiapine—Vomiting—Dapsone—leprosy	0.00043	0.00217	CcSEcCtD
Quetiapine—Mental disorder—Thalidomide—leprosy	0.000427	0.00216	CcSEcCtD
Quetiapine—Malnutrition—Thalidomide—leprosy	0.000425	0.00214	CcSEcCtD
Quetiapine—Headache—Dapsone—leprosy	0.000424	0.00214	CcSEcCtD
Quetiapine—CHRM3—testis—leprosy	0.000419	0.00379	CbGeAlD
Quetiapine—Flatulence—Thalidomide—leprosy	0.000418	0.00211	CcSEcCtD
Quetiapine—Tension—Thalidomide—leprosy	0.000417	0.0021	CcSEcCtD
Quetiapine—Dysgeusia—Thalidomide—leprosy	0.000416	0.0021	CcSEcCtD
Quetiapine—Nervousness—Thalidomide—leprosy	0.000412	0.00208	CcSEcCtD
Quetiapine—CHRM3—nervous system—leprosy	0.000411	0.00372	CbGeAlD
Quetiapine—Back pain—Thalidomide—leprosy	0.000411	0.00207	CcSEcCtD
Quetiapine—HTR1A—nervous system—leprosy	0.00041	0.0037	CbGeAlD
Quetiapine—Muscle spasms—Thalidomide—leprosy	0.000408	0.00206	CcSEcCtD
Quetiapine—Nausea—Dapsone—leprosy	0.000402	0.00203	CcSEcCtD
Quetiapine—Vision blurred—Thalidomide—leprosy	0.0004	0.00202	CcSEcCtD
Quetiapine—HTR7—testis—leprosy	0.000399	0.0036	CbGeAlD
Quetiapine—Tremor—Thalidomide—leprosy	0.000398	0.00201	CcSEcCtD
Quetiapine—Ill-defined disorder—Thalidomide—leprosy	0.000394	0.00199	CcSEcCtD
Quetiapine—Anaemia—Thalidomide—leprosy	0.000392	0.00198	CcSEcCtD
Quetiapine—HTR7—nervous system—leprosy	0.000392	0.00354	CbGeAlD
Quetiapine—Agitation—Thalidomide—leprosy	0.00039	0.00197	CcSEcCtD
Quetiapine—Angioedema—Thalidomide—leprosy	0.000388	0.00196	CcSEcCtD
Quetiapine—Malaise—Thalidomide—leprosy	0.000383	0.00193	CcSEcCtD
Quetiapine—Vertigo—Thalidomide—leprosy	0.000382	0.00193	CcSEcCtD
Quetiapine—Syncope—Thalidomide—leprosy	0.000381	0.00192	CcSEcCtD
Quetiapine—Leukopenia—Thalidomide—leprosy	0.00038	0.00192	CcSEcCtD
Quetiapine—ADRA1A—nervous system—leprosy	0.000378	0.00341	CbGeAlD
Quetiapine—DRD2—testis—leprosy	0.000377	0.00341	CbGeAlD
Quetiapine—Palpitations—Thalidomide—leprosy	0.000375	0.00189	CcSEcCtD
Quetiapine—Loss of consciousness—Thalidomide—leprosy	0.000373	0.00188	CcSEcCtD
Quetiapine—Cough—Thalidomide—leprosy	0.000371	0.00187	CcSEcCtD
Quetiapine—DRD2—nervous system—leprosy	0.00037	0.00334	CbGeAlD
Quetiapine—Convulsion—Thalidomide—leprosy	0.000368	0.00186	CcSEcCtD
Quetiapine—ADRA2C—testis—leprosy	0.000367	0.00331	CbGeAlD
Quetiapine—Hypertension—Thalidomide—leprosy	0.000367	0.00185	CcSEcCtD
Quetiapine—Arthralgia—Thalidomide—leprosy	0.000362	0.00182	CcSEcCtD
Quetiapine—Chest pain—Thalidomide—leprosy	0.000362	0.00182	CcSEcCtD
Quetiapine—Myalgia—Thalidomide—leprosy	0.000362	0.00182	CcSEcCtD
Quetiapine—Anxiety—Thalidomide—leprosy	0.00036	0.00182	CcSEcCtD
Quetiapine—ADRA2C—nervous system—leprosy	0.00036	0.00325	CbGeAlD
Quetiapine—HRH1—tendon—leprosy	0.00036	0.00325	CbGeAlD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000359	0.00181	CcSEcCtD
Quetiapine—Discomfort—Thalidomide—leprosy	0.000357	0.0018	CcSEcCtD
Quetiapine—Dry mouth—Thalidomide—leprosy	0.000354	0.00178	CcSEcCtD
Quetiapine—ADRA2A—tendon—leprosy	0.000353	0.00319	CbGeAlD
Quetiapine—Confusional state—Thalidomide—leprosy	0.000349	0.00176	CcSEcCtD
Quetiapine—Infection—Thalidomide—leprosy	0.000344	0.00174	CcSEcCtD
Quetiapine—Shock—Thalidomide—leprosy	0.000341	0.00172	CcSEcCtD
Quetiapine—Nervous system disorder—Thalidomide—leprosy	0.00034	0.00172	CcSEcCtD
Quetiapine—Thrombocytopenia—Thalidomide—leprosy	0.000339	0.00171	CcSEcCtD
Quetiapine—Tachycardia—Thalidomide—leprosy	0.000338	0.00171	CcSEcCtD
Quetiapine—Skin disorder—Thalidomide—leprosy	0.000337	0.0017	CcSEcCtD
Quetiapine—Hyperhidrosis—Thalidomide—leprosy	0.000335	0.00169	CcSEcCtD
Quetiapine—Anorexia—Thalidomide—leprosy	0.00033	0.00167	CcSEcCtD
Quetiapine—Hypotension—Thalidomide—leprosy	0.000324	0.00163	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000316	0.00159	CcSEcCtD
Quetiapine—Insomnia—Thalidomide—leprosy	0.000313	0.00158	CcSEcCtD
Quetiapine—Paraesthesia—Thalidomide—leprosy	0.000311	0.00157	CcSEcCtD
Quetiapine—Dyspnoea—Thalidomide—leprosy	0.000309	0.00156	CcSEcCtD
Quetiapine—Somnolence—Thalidomide—leprosy	0.000308	0.00156	CcSEcCtD
Quetiapine—Dyspepsia—Thalidomide—leprosy	0.000305	0.00154	CcSEcCtD
Quetiapine—Decreased appetite—Thalidomide—leprosy	0.000301	0.00152	CcSEcCtD
Quetiapine—HTR2A—tendon—leprosy	0.000301	0.00271	CbGeAlD
Quetiapine—Gastrointestinal disorder—Thalidomide—leprosy	0.000299	0.00151	CcSEcCtD
Quetiapine—Fatigue—Thalidomide—leprosy	0.000299	0.00151	CcSEcCtD
Quetiapine—HRH1—testis—leprosy	0.000298	0.00269	CbGeAlD
Quetiapine—Constipation—Thalidomide—leprosy	0.000296	0.0015	CcSEcCtD
Quetiapine—Pain—Thalidomide—leprosy	0.000296	0.0015	CcSEcCtD
Quetiapine—ADRA2A—testis—leprosy	0.000293	0.00264	CbGeAlD
Quetiapine—HRH1—nervous system—leprosy	0.000292	0.00264	CbGeAlD
Quetiapine—ADRA2A—nervous system—leprosy	0.000287	0.00259	CbGeAlD
Quetiapine—Feeling abnormal—Thalidomide—leprosy	0.000286	0.00144	CcSEcCtD
Quetiapine—Gastrointestinal pain—Thalidomide—leprosy	0.000283	0.00143	CcSEcCtD
Quetiapine—Abdominal pain—Thalidomide—leprosy	0.000274	0.00138	CcSEcCtD
Quetiapine—Body temperature increased—Thalidomide—leprosy	0.000274	0.00138	CcSEcCtD
Quetiapine—Hypersensitivity—Thalidomide—leprosy	0.000255	0.00129	CcSEcCtD
Quetiapine—HTR2A—testis—leprosy	0.000249	0.00225	CbGeAlD
Quetiapine—Asthenia—Thalidomide—leprosy	0.000249	0.00126	CcSEcCtD
Quetiapine—Pruritus—Thalidomide—leprosy	0.000245	0.00124	CcSEcCtD
Quetiapine—HTR2A—nervous system—leprosy	0.000244	0.00221	CbGeAlD
Quetiapine—Diarrhoea—Thalidomide—leprosy	0.000237	0.0012	CcSEcCtD
Quetiapine—Dizziness—Thalidomide—leprosy	0.000229	0.00116	CcSEcCtD
Quetiapine—CYP2D6—testis—leprosy	0.000227	0.00205	CbGeAlD
Quetiapine—CYP3A4—nervous system—leprosy	0.000226	0.00204	CbGeAlD
Quetiapine—CYP2D6—nervous system—leprosy	0.000222	0.00201	CbGeAlD
Quetiapine—Vomiting—Thalidomide—leprosy	0.00022	0.00111	CcSEcCtD
Quetiapine—Rash—Thalidomide—leprosy	0.000219	0.0011	CcSEcCtD
Quetiapine—Dermatitis—Thalidomide—leprosy	0.000218	0.0011	CcSEcCtD
Quetiapine—Headache—Thalidomide—leprosy	0.000217	0.0011	CcSEcCtD
Quetiapine—Nausea—Thalidomide—leprosy	0.000206	0.00104	CcSEcCtD
Quetiapine—ABCB1—testis—leprosy	0.000163	0.00147	CbGeAlD
Quetiapine—ABCB1—nervous system—leprosy	0.00016	0.00145	CbGeAlD
